Definitive Contract 75D30120C09828

Award Date 9/11/20
Potential Completion Date 9/10/23
Potential Value $1.5M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Becton, Dickinson and Company, doing business as BD, was awarded a $226,336.94 purchase order contract by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is funded by the Department of Health and Human Services (HHS) and will provide products or services in support of the CDC's programs from BD's place of performance in Chamblee, Georgia. The contract has a period of performance starting July 21, 2023 through October 6, 2023 and utilizes a...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson & Co. (BD), a manufacturer of medical devices, instruments, and related products. The $80,000 firm fixed-price purchase order is for antimicrobial resistance data and does not have a set-aside designation. BD has received numerous federal contract awards as both a prime and subcontractor, including several indefinite delivery/indefinite quantity (IDIQ) contracts with the...
This federal contract award is for Becton, Dickinson And Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The contract, valued at $428,903.24, was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh and does not have a set-aside designation. The contract is a delivery order contract of the type Indefinite Delivery/Indefinite Quantity (IDIQ), which allows the government to place orders for...
The Centers for Disease Control and Prevention (CDC) awarded a $38,093 purchase order to Becton, Dickinson and Company for antibodies and reagents. Becton, Dickinson and Company, doing business as BD, will provide the requested bioscience products from its Franklin Lakes, New Jersey location to support CDC programs. No additional details were provided on the original solicitation or use of the antibodies and reagents. The single award was made on a firm-fixed-price basis with performance...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to Becton, Dickinson & Co. (BD), a medical device manufacturer, to provide laboratory equipment and services. The contract, valued at $132,239.00, has an ultimate completion date of September 7, 2018. This award is not associated with a set-aside program. BD has received numerous federal contract awards from agencies such as the Department of Veterans Affairs, Defense Logistics...
The U.S. Centers for Disease Control and Prevention (CDC) in Pittsburgh has awarded a $49,032 firm-fixed-price purchase order to Becton, Dickinson and Company (BD) for the BD Accuri C6+ System. This award, which has no set-aside designation, will support the agency's biomedical research and clinical programs. BD, a global medical technology manufacturer, has extensive experience providing specialized equipment and supplies, including flow cytometers and associated reagents, to various federal...
This $121,493 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD) for instrument service. The contract has no set-aside designation. BD is a global medical technology company that specializes in providing instruments, reagents, and services to support biomedical research and clinical applications, particularly in the areas of flow cytometry, cell imaging, and genomics. BD has extensive experience providing...
This federal contract award is for the purchase of a BD FACSYMPHONY A3 Cell Analyzer by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) in Pittsburgh. The prime contractor is Becton, Dickinson and Company (BD), a global medical technology company that provides instruments, reagents, and services to support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics technologies. The contract is a firm fixed-price...
This federal contract award is for a service agreement with Becton, Dickinson and Company (BD) to provide BD flow cytometers. The contract, worth $94,554.12, was awarded by the Centers for Disease Control and Prevention (CDC) on July 21, 2022, and has a completion date of September 20, 2023. The contract is a firm fixed-price purchase order and does not have a set-aside designation. BD is a global medical technology company that provides instruments, reagents, and services supporting...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded Becton, Dickinson And Company (BD), a manufacturer of medical devices and supplies, a firm fixed-price purchase order valued at $20,116.80 for high parameter custom conjugates. This award does not have a set-aside designation. The award has a completion date of August 15, 2024. BD is a prime contractor that has received numerous federal contract awards...

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a definitive contract valued at approximately $1.45 million to Becton, Dickinson and Company, doing business as BD, for real-time access to inpatient clinical, laboratory, medication, and outcome data. The firm fixed price contract runs from September 2020 through September 2023 and will be performed in San Diego, California. BD will deliver data integration and analytics services to support CDC programs that monitor healthcare-associated infections and antibiotic resistance. No subcontractors or set aside designations were identified. The award draws upon CDC's expertise in disease surveillance and prevention to improve patient safety and care quality through enhanced clinical decision-making.

Generated 12/24/23, 11:35 PM